Ruoqiong Cao

990 total citations
22 papers, 705 citations indexed

About

Ruoqiong Cao is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Ruoqiong Cao has authored 22 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Ruoqiong Cao's work include Tuberculosis Research and Epidemiology (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and Immune responses and vaccinations (6 papers). Ruoqiong Cao is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and Immune responses and vaccinations (6 papers). Ruoqiong Cao collaborates with scholars based in United States, China and Canada. Ruoqiong Cao's co-authors include Vishwanath Venketaraman, James Owens, Kimberly To, Aram Yegiazaryan, Hicret Islamoglu, Garrett Teskey, Jianfei Wang, Li Cao, Yangyang Sun and Yu Qiu and has published in prestigious journals such as Cell stem cell, Antimicrobial Agents and Chemotherapy and Frontiers in Immunology.

In The Last Decade

Ruoqiong Cao

20 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruoqiong Cao United States 13 266 224 188 127 117 22 705
Mehmet Sami Serin Türkiye 16 275 1.0× 140 0.6× 308 1.6× 36 0.3× 63 0.5× 53 843
Christoph R. Werner Germany 12 341 1.3× 185 0.8× 98 0.5× 105 0.8× 239 2.0× 46 994
Caio César de Souza Alves Brazil 16 129 0.5× 131 0.6× 188 1.0× 99 0.8× 158 1.4× 56 687
Mary Ko Canada 14 316 1.2× 332 1.5× 422 2.2× 55 0.4× 43 0.4× 29 944
Liliana Håversen Sweden 14 242 0.9× 76 0.3× 297 1.6× 110 0.9× 205 1.8× 29 1.0k
Evan O. Gregg United Kingdom 16 183 0.7× 129 0.6× 133 0.7× 147 1.2× 174 1.5× 28 666
Shinobu Kobayashi Japan 15 113 0.4× 114 0.5× 212 1.1× 68 0.5× 80 0.7× 38 688
Mark Baker United States 12 137 0.5× 100 0.4× 457 2.4× 88 0.7× 136 1.2× 15 1.0k
Thiago Vinícius Ávila Brazil 13 165 0.6× 118 0.5× 144 0.8× 33 0.3× 191 1.6× 17 668
Peter Mayser Germany 17 502 1.9× 144 0.6× 91 0.5× 24 0.2× 69 0.6× 59 846

Countries citing papers authored by Ruoqiong Cao

Since Specialization
Citations

This map shows the geographic impact of Ruoqiong Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoqiong Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoqiong Cao more than expected).

Fields of papers citing papers by Ruoqiong Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruoqiong Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoqiong Cao. The network helps show where Ruoqiong Cao may publish in the future.

Co-authorship network of co-authors of Ruoqiong Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Ruoqiong Cao. A scholar is included among the top collaborators of Ruoqiong Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruoqiong Cao. Ruoqiong Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Ruoqiong, Duy T. Le, Laure Maneix, et al.. (2025). Rare epigenetic alterations are conserved across hematopoietic differentiation stages after mycobacterial infection. JCI Insight. 11(2).
2.
3.
Mills, Taylor, Bailee Kain, Etienne Danis, et al.. (2024). A distinct metabolic and epigenetic state drives trained immunity in HSC-derived macrophages from autoimmune mice. Cell stem cell. 31(11). 1630–1649.e8. 19 indexed citations
4.
Cao, Ruoqiong, et al.. (2024). Forged in the fire: Lasting impacts of inflammation on hematopoietic progenitors. Experimental Hematology. 134. 104215–104215. 14 indexed citations
5.
Kain, Bailee, Ruoqiong Cao, Duy T. Le, et al.. (2023). Hematopoietic stem and progenitor cells confer cross-protective trained immunity in mouse models. iScience. 26(9). 107596–107596. 22 indexed citations
6.
Owens, James, Ruoqiong Cao, Afsal Kolloli, et al.. (2022). Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs. Antioxidants. 11(4). 673–673. 11 indexed citations
7.
Vanaja, K., Ruoqiong Cao, Vishwanath Venketaraman, & Guru V. Betageri. (2022). Liposomes as Carriers for the Delivery of Efavirenz in Combination with Glutathione—An Approach to Combat Opportunistic Infections. Applied Sciences. 12(3). 1468–1468. 10 indexed citations
8.
Cao, Ruoqiong, Kimberly To, James Owens, et al.. (2021). Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection. BioMolecular Concepts. 12(1). 46–54. 9 indexed citations
9.
To, Kimberly, Ruoqiong Cao, Aram Yegiazaryan, et al.. (2021). The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering the Immune Responses against Mycobacterium bovis BCG Strain in Individuals with Type 2 Diabetes. BioMolecular Concepts. 12(1). 16–26. 10 indexed citations
10.
Cao, Ruoqiong, Afsal Kolloli, Ranjeet Kumar, et al.. (2021). Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection. Applied Sciences. 11(17). 8274–8274. 12 indexed citations
11.
To, Kimberly, Ruoqiong Cao, Aram Yegiazaryan, et al.. (2021). Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes. Frontiers in Cellular and Infection Microbiology. 11. 657775–657775. 25 indexed citations
12.
To, Kimberly, Ruoqiong Cao, Aram Yegiazaryan, James Owens, & Vishwanath Venketaraman. (2020). General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus. Journal of Clinical Medicine. 9(8). 2541–2541. 147 indexed citations
13.
Ashley, David J. B., Ruoqiong Cao, Kimberly To, et al.. (2020). Cyclic Peptide [R4W4] in Improving the Ability of First-Line Antibiotics to Inhibit Mycobacterium tuberculosis Inside in vitro Human Granulomas. Frontiers in Immunology. 11. 1677–1677. 9 indexed citations
14.
Ashley, David J. B., Ruoqiong Cao, Kimberly To, et al.. (2020). Antimycobacterial Effects of Everolimus in a Human Granuloma Model. Journal of Clinical Medicine. 9(7). 2043–2043. 28 indexed citations
15.
Cao, Ruoqiong, Garrett Teskey, Hicret Islamoglu, et al.. (2019). Flavonoid Mixture Inhibits Mycobacterium tuberculosis Survival and Infectivity. Molecules. 24(5). 851–851. 19 indexed citations
16.
Cao, Ruoqiong, Hicret Islamoglu, Garrett Teskey, et al.. (2019). The preclinical candidate indole-2-carboxamide improves immune responses to Mycobacterium tuberculosis infection in healthy subjects and individuals with type 2 diabetes. International Microbiology. 23(2). 161–170. 7 indexed citations
17.
Cao, Ruoqiong, et al.. (2018). Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis. Antimicrobial Agents and Chemotherapy. 62(11). 28 indexed citations
18.
Teskey, Garrett, et al.. (2018). Glutathione as a Marker for Human Disease. Advances in clinical chemistry. 87. 141–159. 156 indexed citations
19.
Teskey, Garrett, Ruoqiong Cao, Hicret Islamoglu, et al.. (2018). The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis. Frontiers in Immunology. 9. 42 indexed citations
20.
Islamoglu, Hicret, Ruoqiong Cao, Garrett Teskey, et al.. (2018). Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection. Journal of Clinical Medicine. 7(3). 40–40. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehmet Sami Serin Breakdown of academic impact, for papers by Christoph R. Werner Breakdown of academic impact, for papers by Caio César de Souza Alves Breakdown of academic impact, for papers by Mary Ko Breakdown of academic impact, for papers by Liliana Håversen Breakdown of academic impact, for papers by Evan O. Gregg Breakdown of academic impact, for papers by Shinobu Kobayashi Breakdown of academic impact, for papers by Mark Baker Breakdown of academic impact, for papers by Thiago Vinícius Ávila Breakdown of academic impact, for papers by Peter Mayser
Rankless by CCL
2026